rs201151358

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4BP6_Very_StrongBS1BS2

The NM_001278116.2(L1CAM):​c.113C>T​(p.Thr38Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00057 in 1,206,671 control chromosomes in the GnomAD database, including 1 homozygotes. There are 220 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T38T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00026 ( 0 hom., 8 hem., cov: 22)
Exomes 𝑓: 0.00060 ( 1 hom. 212 hem. )

Consequence

L1CAM
NM_001278116.2 missense

Scores

3
8
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.50

Publications

3 publications found
Variant links:
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
L1CAM Gene-Disease associations (from GenCC):
  • L1 syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked hydrocephalus with stenosis of the aqueduct of Sylvius
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • MASA syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • X-linked complicated corpus callosum dysgenesis
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • X-linked complicated spastic paraplegia type 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.268756).
BP6
Variant X-153872676-G-A is Benign according to our data. Variant chrX-153872676-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 458210.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000261 (29/111173) while in subpopulation NFE AF = 0.000359 (19/52954). AF 95% confidence interval is 0.000235. There are 0 homozygotes in GnomAd4. There are 8 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 8 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
L1CAMNM_001278116.2 linkc.113C>T p.Thr38Met missense_variant Exon 4 of 29 ENST00000370060.7 NP_001265045.1
L1CAMNM_000425.5 linkc.113C>T p.Thr38Met missense_variant Exon 3 of 28 NP_000416.1
L1CAMNM_024003.3 linkc.113C>T p.Thr38Met missense_variant Exon 3 of 27 NP_076493.1
L1CAMNM_001143963.2 linkc.98C>T p.Thr33Met missense_variant Exon 2 of 26 NP_001137435.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
L1CAMENST00000370060.7 linkc.113C>T p.Thr38Met missense_variant Exon 4 of 29 5 NM_001278116.2 ENSP00000359077.1
ENSG00000284987ENST00000646191.1 linkn.*155C>T non_coding_transcript_exon_variant Exon 4 of 5 ENSP00000493873.1
ENSG00000284987ENST00000646191.1 linkn.*155C>T 3_prime_UTR_variant Exon 4 of 5 ENSP00000493873.1

Frequencies

GnomAD3 genomes
AF:
0.000261
AC:
29
AN:
111173
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000295
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000954
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000359
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000251
AC:
46
AN:
183381
AF XY:
0.000251
show subpopulations
Gnomad AFR exome
AF:
0.000456
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000476
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000602
AC:
659
AN:
1095498
Hom.:
1
Cov.:
30
AF XY:
0.000587
AC XY:
212
AN XY:
360902
show subpopulations
African (AFR)
AF:
0.000266
AC:
7
AN:
26357
American (AMR)
AF:
0.0000568
AC:
2
AN:
35202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19370
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30195
South Asian (SAS)
AF:
0.0000370
AC:
2
AN:
54089
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40523
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4128
European-Non Finnish (NFE)
AF:
0.000756
AC:
635
AN:
839624
Other (OTH)
AF:
0.000283
AC:
13
AN:
46010
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.436
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000261
AC:
29
AN:
111173
Hom.:
0
Cov.:
22
AF XY:
0.000240
AC XY:
8
AN XY:
33357
show subpopulations
African (AFR)
AF:
0.000295
AC:
9
AN:
30546
American (AMR)
AF:
0.0000954
AC:
1
AN:
10481
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2640
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3510
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2570
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6079
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.000359
AC:
19
AN:
52954
Other (OTH)
AF:
0.00
AC:
0
AN:
1475
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000260
Hom.:
2
Bravo
AF:
0.000223
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00104
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.000214
AC:
26
EpiCase
AF:
0.000436
EpiControl
AF:
0.000652

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 05, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spastic paraplegia Benign:1
Mar 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Feb 06, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

X-linked hydrocephalus syndrome;C0795953:MASA syndrome;C1839909:X-linked complicated corpus callosum dysgenesis Benign:1
Jul 06, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Sep 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26891472, 19846429) -

L1CAM-related disorder Benign:1
Dec 29, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.62
.;D;.;.;T;T;T;T
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.89
D;D;.;D;D;D;D;D
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.27
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.8
.;M;.;M;.;.;.;.
PhyloP100
2.5
PrimateAI
Uncertain
0.60
T
PROVEAN
Pathogenic
-4.5
D;D;D;D;D;D;D;D
REVEL
Uncertain
0.29
Sift
Uncertain
0.0020
D;D;D;D;D;D;D;D
Sift4G
Pathogenic
0.0010
D;D;D;D;.;.;D;.
Polyphen
1.0, 1.0
.;D;.;D;.;.;.;.
Vest4
0.55
MVP
0.78
MPC
1.5
ClinPred
0.20
T
GERP RS
4.7
Varity_R
0.52
gMVP
0.88
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201151358; hg19: chrX-153138131; API